The Osteosarcoma Institute
@OSInstitute
Followers
1K
Following
869
Media
405
Statuses
852
We fund research for osteosarcoma, a rare bone cancer affecting mainly children, adolescents, and young adults. Join us in #ConcentratingOnTheCure.
Dallas, TX
Joined November 2017
She helped redefine breast cancer. Now Christina Curtis, PhD, MSc, is applying her genomic modeling and AI tools to osteosarcoma. With support from OSI, she is tracing tumors back to their origins to unlock better treatments. https://t.co/oDRclk66Ip
0
0
0
Giving this December means more. Your donation supports #osteosarcoma research, offers greater impact, and helps reach our $300,000 goal. As always, 100% goes to research. Give here: https://t.co/OClGo01WP2
#CancerResearch #FundTheCure
0
0
2
A $500K project led by John Maris, MD (@ChildrensPhila) with Alejandro Sweet-Cordero, MD (@UCSF) is developing more precise CAR T-cell therapies that target proteins on osteosarcoma cells. Read more: https://t.co/TI2Sh5JNxE
#ChildhoodCancerReasearch #CancerResearch
1
2
7
At 17, Brandon Morgan faced osteosarcoma head-on and documented every step. His film 30 Weeks shows the truth behind this disease and its treatment. Now in remission, Brandon is using his voice to raise awareness. Read more stories like Brandon’s: https://t.co/hKkV5A54ZB
0
1
4
Now available - the webcast & slides from the #FDA & @OsteosarcomaInst Oct. 10 workshop on Advancing Osteosarcoma Drug Development! To access these files, scroll down to the materials section on the event’s web page. #OCE #Osteosarcoma #CancerResearch 👉 https://t.co/3P1lukaaMB
0
3
2
The @US_FDA /OSI Workshop gathered patients, parents, researchers, clinicians, biopharma, and regulators to tackle osteosarcoma. Key takeaways: · Progress has stalled · Biology is complex · New drugs show promise · Coordination is critical Watch: https://t.co/fD5UXuEedF
0
0
0
Your gift triples this December. All donations through Dec. 31 will be double matched. Your $1 becomes $3 for research. Help us bring new hope to families facing #osteosarcoma. Give today: https://t.co/OClGo01WP2
#CancerResearch #FundTheCure
0
0
0
BrightSeq is a transformative new collaboration studying how ctDNA found in blood may help doctors better determine prognosis and monitor treatment response in osteosarcoma. Read more: https://t.co/3LSzPN8HZX
0
0
3
Today, OSI turns 8. Since 2017, we have committed over $11.2 million to osteosarcoma research and clinical trials. we are actively supporting 14 studies, each aimed at improving treatment options and outcomes. Join us: https://t.co/bm0J0RalR9
0
0
6
The OSI awarded over $1.5 million through our 2024-2025 Grant Cycle to fund four innovative research projects on osteosarcoma, exploring topics such as engineered CAR T-cells and telomere-targeting therapies. https://t.co/TI2Sh5JNxE
0
0
6
More than 370 people joined the @US_FDA / OSI workshop on Oct. 10 to share ideas on how to advance osteosarcoma research and treatment. View a recording of the workshop: https://t.co/fD5UXuEM3d
#Osteosarcoma #FDAWorkshop
0
0
2
A new approach to finding a cure for #osteosarcoma brings together investigators from eight of the top cancer centers in North America. Learn about how the OSI is joining with @break_cancer, @StBaldricks, and others in a #radicalcollaboration: https://t.co/Mrc6V87LxG
1
1
5
Osteosarcoma treatments have not changed in 30+ years. Dr. Robin Parihar’s research funded by the OSI is testing a new combination therapy using natural killer cells and CAR T-cells. The goal is clinical trials in 2026. See his update: https://t.co/KuktvSdMG6
0
0
5
Register to join virtually now! Registration is open throughout this event today, Oct. 10th between 9:30am to 5pm ET. https://t.co/rPyLhFQ0SW
fda.gov
Meeting information for FDA/The Osteosarcoma Institute (OSI) Workshop
Join us today! FDA & @OSInstitute convening stakeholders Oct 10 to identify barriers, increase trial efficiency & advance innovative designs. New #osteosarcoma therapies needed NOW. Join a conversation that could change outcomes: https://t.co/6jGhAjWG5h
#RareDiseaseResearch
0
0
1
The OSI 2025-2026 Grant Cycle closes Oct. 24 at 12 p.m. EDT. Funding: $25K–$800K for osteosarcoma research, including clinical, translational, and high-risk projects. Apply via ProposalCentral. https://t.co/zvb604GOrT
#CancerGrants
0
0
2
Outcomes for osteosarcoma haven’t improved in 40+ years. Families and foundations joined Break Through Cancer to change that. A $15M initiative now brings together 20+ researchers across 8 cancer centers — the largest effort of its kind. https://t.co/zIB4YreeDs
2
5
15
As a collegiate track and field athlete, Erin was diagnosed with osteosarcoma, a rare bone cancer, after a fall that broke her leg. When chemotherapy failed, she chose above-knee amputation. Erin empowers those who feel unseen to fight. Watch at https://t.co/wLVMebpxf5
1
1
3
Thursday, we were joined by Alanna Church, MD, on OsteoBites to discuss, "Insights from the AACR Special Conference in Cancer Research: Discovery and Innovation in Pediatric Cancer". Watch the full episode here: https://t.co/V4aJdjrwT5
#MIBAgents #MakeItBetter #osteosarcoma
0
1
2
When osteosarcoma spreads, survival is less than 25%. Dr. Poul Sorensen’s research, funded by the OSI, has identified new targets for immunotherapy and is now testing antibody-based approaches to improve outcomes Watch his update: https://t.co/ix51fjXqM4
0
0
3
Just one more week until the @US_FDA and the OSI Workshop on Oct. 10. Join researchers, advocates, and regulators to explore new directions in osteosarcoma drug development. Free and open to all: https://t.co/4Ba8U2StzJ
#Osteosarcoma #FDAWorkshop
0
0
1